Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
NCT01020968
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Dilated Cardiomyopathy
Interventions
BIOLOGICAL:
Ixmyelocel-T
OTHER:
Vehicle Control
Sponsor
Vericel Corporation